Global Analysis of Proteolysis in Apoptosis
细胞凋亡中蛋白水解的整体分析
基本信息
- 批准号:8054743
- 负责人:
- 金额:$ 28.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AminesApoptosisApoptoticAreaAspartateBiological AssayBiological ProcessBiologyCaspaseCell DeathCell physiologyCellsCleaved cellDataDatabasesDevelopmentDiseaseDrug Delivery SystemsEngineeringEnzymesEstersEventFeedbackFractionationGoalsHarvestHomeostasisHourHumanIn VitroInduction of ApoptosisJurkat CellsLabelLifeLinkLogicMalignant NeoplasmsMapsMass Spectrum AnalysisMediatingMethodsNeurodegenerative DisordersPathway interactionsPeptide HydrolasesPeptidesProcessProtease GeneProtein AnalysisProteinsProteolysisProteomicsProtocols documentationReportingResearchResearch PersonnelSamplingSeaSignal TransductionSiteSmall Interfering RNAStrokeSupporting CellTestingTimeWestern BlottingWorkcancer cellcancer therapyinhibitor/antagonistknock-downliquid chromatography mass spectrometryprogramsresearch studysubtiligasetherapeutic target
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of the proposed work is to elucidate the process leading to programmed cell death (apoptosis) by applying a new and general method we have developed for global proteomic profiling of proteolysis ("degradomics"). Our hypothesis is that proteases, and in particular caspases, act like demolition experts to target key control points to disrupt cellular homeostasis. Finding these points of attack, identifying the proteases involved, and determining the sequence of events are all fundamental to understanding cell death. Apoptosis is a key cellular process that regulates diseases such as cancer, stroke and neurodegenerative diseases among others. By discovering the critical regulatory points in apoptosis, new and important drug targets for these diseases may be identified.
Apoptosis is dominated by proteolytic events that are primarily mediated by caspases, aspartate specific proteases. However, the protein substrates they cleave and the cascades they ignite are only partially understood. This proposal applies a new and general method that allows one to selectively label and enrich for a-amino peptides, the product of proteolysis. Tagged products can be readily identified and sequenced by LC/MS/MS. Preliminary studies in Jurkat cells induced to apoptose have already identified 68 asparate cleavage sites of which two-thirds are new substrates. Data suggest the total set of caspase substrates may be up to 3 to 6-times larger than the entire data base of reported caspase substrates across all cells. A combination of cellular ("forward") and in vitro ("reverse") degradomics experiments are proposed. These experiments will provide the most comprehensive map to date of proteins cleaved and proteases responsible for intrinsic and extrinsic apoptosis pathways. There are over a 1000 different human protease genes. The degradomics approaches developed here for caspases will be general and applicable to mapping other protease signaling events.
Proteases are involved in most areas of biology and mediate many diseases. It is known that prosurvival proteins are cleaved during apoptosis and many cancer treatments involve compounds that selectively induce apoptosis through inhibiting prosurvival proteins in cancer cells. Thus, in addition to mapping the process of apoptosis and demonstrating a general degradomics method, the proposed work may identify new drug targets for the development of cancer therapies.
描述(由申请人提供):拟议工作的长期目标是通过应用我们为蛋白质水解的全局蛋白质组学分析(“降解组学”)开发的新的通用方法来阐明导致程序性细胞死亡(细胞凋亡)的过程。我们的假设是,蛋白酶,特别是半胱天冬酶,就像破坏专家一样,针对关键控制点来破坏细胞稳态。找到这些攻击点、识别所涉及的蛋白酶以及确定事件的顺序都是理解细胞死亡的基础。细胞凋亡是调节癌症、中风和神经退行性疾病等疾病的关键细胞过程。通过发现细胞凋亡的关键调节点,可以确定这些疾病的新的重要药物靶点。
细胞凋亡主要由蛋白水解事件主导,蛋白水解事件主要由半胱天冬酶、天冬氨酸特异性蛋白酶介导。然而,它们裂解的蛋白质底物和它们引发的级联反应仅被部分了解。该提案应用了一种新的通用方法,允许人们选择性地标记和富集蛋白质水解产物α-氨基肽。标记的产品可以通过 LC/MS/MS 轻松识别和测序。对诱导凋亡的 Jurkat 细胞的初步研究已经确定了 68 个天冬氨酸切割位点,其中三分之二是新底物。数据表明,Caspase 底物的总集可能比所有细胞中报道的 Caspase 底物的整个数据库大 3 至 6 倍。提出了细胞(“正向”)和体外(“反向”)降解组学实验的组合。这些实验将提供迄今为止最全面的负责内在和外在细胞凋亡途径的蛋白质和蛋白酶的图谱。有超过 1000 种不同的人类蛋白酶基因。这里开发的半胱天冬酶降解组学方法将是通用的,适用于绘制其他蛋白酶信号事件。
蛋白酶涉及生物学的大部分领域并介导许多疾病。众所周知,促存活蛋白在细胞凋亡过程中被裂解,并且许多癌症治疗涉及通过抑制癌细胞中的促存活蛋白来选择性诱导细胞凋亡的化合物。因此,除了绘制细胞凋亡过程并展示通用降解组学方法之外,拟议的工作还可以确定用于开发癌症疗法的新药物靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES A WELLS其他文献
JAMES A WELLS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES A WELLS', 18)}}的其他基金
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
基于新蛋白质工程的工具和技术,用于表征癌细胞中的细胞表面蛋白水解,以获得新型新表位生物标志物和药物靶点
- 批准号:
10582604 - 财政年份:2020
- 资助金额:
$ 28.77万 - 项目类别:
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
基于新蛋白质工程的工具和技术,用于表征癌细胞中的细胞表面蛋白水解,以获得新型新表位生物标志物和药物靶点
- 批准号:
10371980 - 财政年份:2020
- 资助金额:
$ 28.77万 - 项目类别:
Surfaceomic technologies and antibodies to probe cell surface proteomes and their interactomes at unprecedented small scale and high-resolution
表面组学技术和抗体以前所未有的小规模和高分辨率探测细胞表面蛋白质组及其相互作用组
- 批准号:
10552328 - 财政年份:2017
- 资助金额:
$ 28.77万 - 项目类别:
Discovering how oncogenes remodel the surfaceome of cells
发现癌基因如何重塑细胞表面组
- 批准号:
10212408 - 财政年份:2017
- 资助金额:
$ 28.77万 - 项目类别:
Affinity-directed tagging of protein binding partners in signaling
信号传导中蛋白质结合伴侣的亲和定向标记
- 批准号:
8628677 - 财政年份:2014
- 资助金额:
$ 28.77万 - 项目类别:
Renewable Antibodies for Post Translational Modifications and Protease Activatio
用于翻译后修饰和蛋白酶激活的可再生抗体
- 批准号:
8702418 - 财政年份:2014
- 资助金额:
$ 28.77万 - 项目类别:
Generation of recombinant thiopeptides to target antimicrobial-resistant bacteria
生成重组硫肽以靶向抗菌素耐药细菌
- 批准号:
8798574 - 财政年份:2014
- 资助金额:
$ 28.77万 - 项目类别:
Affinity-directed tagging of protein binding partners in signaling
信号传导中蛋白质结合伴侣的亲和定向标记
- 批准号:
8871699 - 财政年份:2014
- 资助金额:
$ 28.77万 - 项目类别:
Affinity-directed tagging of protein binding partners in signaling
信号传导中蛋白质结合伴侣的亲和定向标记
- 批准号:
9065515 - 财政年份:2014
- 资助金额:
$ 28.77万 - 项目类别:
Automated System for High-Throughput In Vitro Selection of Recombinant Antibodies
用于重组抗体高通量体外选择的自动化系统
- 批准号:
8247377 - 财政年份:2012
- 资助金额:
$ 28.77万 - 项目类别:
相似国自然基金
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
- 批准号:32360836
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
萱草花细胞程序性凋亡生物钟调控机制研究
- 批准号:32371943
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于VEGFR2/Ca2+信号通路研究可视化针刀“调筋治骨”减轻颈椎病颈肌细胞凋亡的分子机制
- 批准号:82360940
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
STING/ALG-2复合物的结构及其在STING激活诱导的T细胞凋亡中的功能
- 批准号:32371265
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
SIRT2/Annexin A2/autophagy通路形成的分子机制及其在HCC细胞失巢凋亡抵抗中的作用研究
- 批准号:32300626
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration
干性年龄相关性黄斑变性的核酶救援策略
- 批准号:
9892813 - 财政年份:2020
- 资助金额:
$ 28.77万 - 项目类别:
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration
干性年龄相关性黄斑变性的核酶救援策略
- 批准号:
10554297 - 财政年份:2020
- 资助金额:
$ 28.77万 - 项目类别:
Cyclic Peptide Nanoparticles Based Dual-drug Delivery to Treat Prostate Cancer
基于环肽纳米颗粒的双药递送治疗前列腺癌
- 批准号:
9498479 - 财政年份:2018
- 资助金额:
$ 28.77万 - 项目类别:
Development of a novel sulindac amide for colorectal cancer chemoprevention
开发用于结直肠癌化学预防的新型舒林酸酰胺
- 批准号:
8658544 - 财政年份:2010
- 资助金额:
$ 28.77万 - 项目类别:
Development of a novel sulindac amide for colorectal cancer chemoprevention
开发用于结直肠癌化学预防的新型舒林酸酰胺
- 批准号:
8691745 - 财政年份:2010
- 资助金额:
$ 28.77万 - 项目类别: